Skip to main content
. 2009 Apr 7;15(13):1554–1580. doi: 10.3748/wjg.15.1554

Table 1.

Populations at increased risk for C. difficile

Patients who take the following drugs
Antibiotics
Proton pump inhibitors
Valacyclovir
Patient characteristics
IBD
Serous underlying illness-comorbidities
Gastrointestinal surgery/manipulations
Advanced age
Immune-compromising conditions (post transplantation)
Peri-partum
Environment
Prolonged stay in health-care settings
Laboratory factors
Hypoalbuminemia
Low levels of anti-toxin and B antibodies
HHS Vulnerability Disclosure